chemXplore tracks 2 projects in Colombia, of which 2 are active.
Of the active ones, 1 expansion and 1 revamp / retrofit.
Operating EBITDA rose 14.5% on a constant-currency basis, while the gross margin narrowed as sourcing costs increased.
Profit excluding one-off events reached R$47.9bn, up 68% year on year; operating cash flow rose 15% to R$61.8bn.
€15m first tranche of a €35m package to expand a Colombian plant to produce up to 250m doses annually, plus a €1.5m R&D grant for three vaccine candidates.
Long-term contract to upgrade water and sanitation for 866,000 residents, cut losses below 30%, and deploy leak detection and network renewal.
Net profit R$32.7bn; adjusted EBITDA R$59.6bn; investments R$26.8bn. Production and refining records supported cash generation and higher derivatives output.
Exclusive global (ex-Russia) distribution for supramolecular actives in beauty & personal care across Europe, Americas, India and Vietnam; offers deeper penetration and validated efficacy
Sold rights to 63 MW wind project in New Brunswick (with PPA); signed Owner’s Engineering for 64.86 MWp Belorado I solar in Spain; received final payment for sold 200 MW Colombian solar project.
isobutyl acetate +$0.15/lb (NA, LatAm), +$0.28/lb (APAC); n-butyl (excl Eastapure) +$0.15/lb (NA, LatAm); n-propyl +$0.15/lb (NA, LatAm). Cited higher raw-material and energy costs.
New gas accumulation found at Copoazu‑1 (Block GUA‑OFF‑0), 964 m water depth, 36 km offshore; additional gas intervals identified beyond main target; samples taken for lab analysis.
Holcim expands in Colombia, acquiring Cemex assets. The deal adds 20+ sites, boosting 2026 sales by USD 360M. Expected synergies of USD 30M in 3 years, EPS accretive in year one.
